JPRN-UMIN000007543尚未招募未知
Study of the Effect of inhaled Short Acting Beta 2 Agonist(procaterol) on Breathlessness on Exertion in COPD patients. - Study of procaterol on Breathlessness on exertion in COPD patients.
Tokyo Women's Medical University Tohoku University Hospital Wakayama Medical University Tohoku Rosai Hospital0 个研究点目标入组 40 人开始时间: 2012年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A patient will not be eligible for inclusion in this study if any of the following criteria 1. There is a current diagnosis of asthma, in the opinion of the investigator 2. Patients with contraindication of procaterol inhalation. 3. The investigator judge to exclude
研究者
相似试验
已完成
3 期
the effect of Ventolin in the treatment of bronchiolitis in childreAcute bronchiolitisBronchiolitis.IRCT20230413057899N1Kashan University of Medical Sciences80
已完成
不适用
Perioperative effects of inhaled long acting beta2 adrenergic agonist/long acting muscarinic antagonist in patients with untreated COPD requiring surgery for lung cancerCOPD requiring surgery for lung cancerJPRN-UMIN000019358Kyoto Prefectural Universityu of Medicine20
已完成
不适用
Influence of respiratory efforts on b2-agonist induced bronchodilation in mechanically ventilated COPD patientsISRCTN15368477niversity of Crete, Medical School (Greece)10
已完成
3 期
Role of a drug in neonates for the treatment of breathlessness at birth due to retention of fluid in lungCTRI/2017/01/007624St Stephens Hospital20
进行中（未招募）
1 期
The inhaled combination of budesonide-formoterol consists a basic asthma treatment.A helpful specific index for the prognosis of future exacerbation risk and deterioration of lung function,is the Exhaled Nitric Oxide.The objective of the current study is the evaluation of Pulmoton- Elpenhaler in Exhaled Nitric Oxide of patients with bronchial asthma.Bronchial AsthmaEUCTR2014-001029-34-GRELPEN Pharmaceutical Co. Inc